Articles

This past April, Albert Einstein Cancer Center was selected to join the National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP), which, in the words of William J. Tester, MD, FACP, medical director of Einstein’s Cancer Center, offers “an opportunity to bring more resources to our patients.”

Read More ›

Multivitamin use during and after adjuvant chemotherapy did not reduce the risk of cancer recurrence or mortality in patients with stage III colon cancer, according to recently released findings of Cancer and Leukemia Group B (CALGB) 89803. Multivitamin use, however, also did not impact patients’ health negatively.
 
Read More ›

Researchers have developed a tool for predicting individualized risk of local recurrence after breast-conserving surgery (BCS) in women with ductal carcinoma in situ (DCIS). The tool integrates 10 clinicopathologic variables to assist patients and their healthcare professionals decide among various treatment options with the goal of reducing over- and undertreatment of noninvasive breast cancer.
 
Read More ›

Radiation therapy after local surgical therapy should be considered in patients with adenoid cystic carcinoma (ACC) of the breast who are otherwise eligible for radiation therapy, concluded a group of researchers from the University of California-Davis.
 
Read More ›

For men with localized low-risk prostate cancer, there is no rush to decide on a treatment option, according to the National Prostate Cancer Register (NPCR) of Sweden Follow-up Study published online in the Journal of Urology. This suggestion is based on findings that after median follow-up of 8 years, men who underwent prompt radical prostatectomy had no significant difference in the presence of one of three adverse pathology features or in prostate cancer–specific mortality than men who deferred surgery for up to 19 months.
 
Read More ›

“Nurses are increasingly likely to deal with patients using medicinal cannabis and it is important that they put their personal views to one side and deal with the health consequences of that drug use,” said Anita J. Green, summarizing her research with Kay De-Vries in a press release accompanying the article September issue of Journal of Clinical Nursing.
 
Read More ›

Risk-reducing surgery reduced the risk for breast and ovarian cancer in a study of women with BRCA1 or BRCA2 mutations. Prophylactic salpingo-oophorectomy also reduced all-cause and cancer-specific mortality in these high-risk women.
 
Read More ›

Eating a variety of fruits and vegetables may protect smokers against lung cancer, according to new data from a multicenter cohort study.
 
The inverse relationship between variety in vegetable consumption and lung cancer risk was independent of quantity and restricted to current smokers.
 
Read More ›

The US Department of Health and Human Services has expanded coverage of evidence-based tobacco cessation counseling for Medicare beneficiaries, making it possible for all smokers to receive counseling from a qualified physician or other Medicare-recognized practitioner who can help them quit smoking.
 
Previously, Medicare covered tobacco cessation counseling only for individuals with a diagnosed tobacco-related disease or with signs or symptoms of such a disease.
 
Read More ›

Prostate-specific antigen (PSA) measurements at 2 years should capture the majority of low-risk cases that progress after treatment with radical prostatectomy, suggests a new study in the September issue of the Journal of Urology.
 
Read More ›

Page 368 of 376


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: